Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Gerontol Geriatr ; 94: 104349, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33508512

RESUMEN

AIM: Mortality is high in Coronavirus disease 2019 patients with pre-existing comorbidities and advanced age. Associated complications have added to the negative prognosis. Nevertheless, many have fully recovered, even among the most fragile. Factors associated with their survival was investigated. METHODS: Retrospective study of patients aged ≥90 years admitted for COVID-19 to the Internal Medicine wards of two hospitals in Lombardy, Italy. RESULTS: Among 34 patients with SARS-CoV-2 pneumonia, 33 (97.1%) had respiratory failure. Eighteen patients (52.9%) survived and 16 (47.1%) died during hospital stay. Survivors compared to deceased had a significantly longer hospitalization (19 vs. 10 days respectively; p = 0.02), a better PaO2:FiO2 ratio (241 vs. 171 respectively; p = 0.003), higher lymphocyte counts (p = 0.01) and lower serum LDH levels (p < 0.001) at admission. At multivariate analysis only higher PaO2:FiO2 was associated with survival (OR 1.06 [95%CI 1.0-1.03]; p = 0.02). Kaplan-Meier analysis showed a significant difference in event-free survival between patients treated or not with LMWH (p < 0.0001) and between those treated or not with beta-blockers (p = 0.008). Cox regression, performed in the subgroup of patients who received LMWH, did not show significant difference for sex (HR 2.7 [95% CI 0.53-14.3], p = 0.23), CCI (HR 0.7 [95% CI 0.37-1.45], p = 0.38), PaO2:FiO2 ratio (HR 0.98 [95% CI 0.97-1.0], p = 0.07), corticosteroid therapy (HR 0.99 [95% CI 0.22-4.5], p = 0.99) and beta-blocker therapy (HR 2.8 [95% CI 0.56-14,7], p = 0.21). CONCLUSIONS: Despite higher mortality in elderly, treatment with LMWH and betablockers might be associated with better survival. Dedicated studies are required to confirm our result.


Asunto(s)
COVID-19 , Anciano , Heparina de Bajo-Peso-Molecular , Humanos , Italia/epidemiología , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2
2.
Infez Med ; 26(1): 89-92, 2018 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-29525804

RESUMEN

Although its prevalence in resource-rich countries is not precisely estimated, persistent diarrhoea is not a common event if extreme ages are excluded. Enteric pathogens, of various underlying aetiologies, often cause major diarrhoeal syndromes, especially in immunocompromised adults. While there is a rich medical literature regarding HIV-related infections, information about the diagnosis of HIV-infection from diarrhoea as a presenting complaint is scarce. Our case report focuses on a 29-year-old Italian male with persistent diarrhoea who was diagnosed with Giardiasis and subsequently tested for HIV infection, resulting positive. In approaching young adults with persistent diarrhoea, lowering the threshold of suspicion for HIV infection proves useful.


Asunto(s)
Giardiasis/complicaciones , Infecciones por VIH/complicaciones , Adulto , Diarrea/etiología , Infecciones por VIH/diagnóstico , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA